View in EDS HTML Full Text PDF Full Text

Anti-SARS-Cov2 vaccination at the time of the COVID-19 pandemic: suspected adverse events reporting is the milestone of post-marketing surveillance.

Saved in:
Bibliographic Details
Title: Anti-SARS-Cov2 vaccination at the time of the COVID-19 pandemic: suspected adverse events reporting is the milestone of post-marketing surveillance.
Authors: Mariottini A; Department of Neurosciences, Drug and Child Health, University of Florence, Viale Gaetano Pieraccini, 6, 50139, Florence, FI, Italy.; Tuscany Region Multiple Sclerosis Referral Centre, Neurology 2, University Hospital of Careggi, Florence, Italy., Repice AM; Tuscany Region Multiple Sclerosis Referral Centre, Neurology 2, University Hospital of Careggi, Florence, Italy., Barilaro A; Tuscany Region Multiple Sclerosis Referral Centre, Neurology 2, University Hospital of Careggi, Florence, Italy., Massacesi L; Department of Neurosciences, Drug and Child Health, University of Florence, Viale Gaetano Pieraccini, 6, 50139, Florence, FI, Italy. luca.massacesi@unifi.it.; Tuscany Region Multiple Sclerosis Referral Centre, Neurology 2, University Hospital of Careggi, Florence, Italy. luca.massacesi@unifi.it.
Source: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2022 Jul; Vol. 43 (7), pp. 4095-4097. Date of Electronic Publication: 2022 Mar 23.
Publication Type: Letter
Journal Info: Publisher: Springer-Verlag Italia Country of Publication: Italy NLM ID: 100959175 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1590-3478 (Electronic) Linking ISSN: 15901874 NLM ISO Abbreviation: Neurol Sci Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35318561
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Anti-SARS-Cov2 vaccination at the time of the COVID-19 pandemic: suspected adverse events reporting is the milestone of post-marketing surveillance.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mariottini+A%22">Mariottini A</searchLink>; Department of Neurosciences, Drug and Child Health, University of Florence, Viale Gaetano Pieraccini, 6, 50139, Florence, FI, Italy.; Tuscany Region Multiple Sclerosis Referral Centre, Neurology 2, University Hospital of Careggi, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Repice+AM%22">Repice AM</searchLink>; Tuscany Region Multiple Sclerosis Referral Centre, Neurology 2, University Hospital of Careggi, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Barilaro+A%22">Barilaro A</searchLink>; Tuscany Region Multiple Sclerosis Referral Centre, Neurology 2, University Hospital of Careggi, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Massacesi+L%22">Massacesi L</searchLink>; Department of Neurosciences, Drug and Child Health, University of Florence, Viale Gaetano Pieraccini, 6, 50139, Florence, FI, Italy. luca.massacesi@unifi.it.; Tuscany Region Multiple Sclerosis Referral Centre, Neurology 2, University Hospital of Careggi, Florence, Italy. luca.massacesi@unifi.it.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100959175%22">Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology</searchLink> [Neurol Sci] 2022 Jul; Vol. 43 (7), pp. 4095-4097. <i>Date of Electronic Publication: </i>2022 Mar 23.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer-Verlag+Italia%22">Springer-Verlag Italia </searchLink><i>Country of Publication: </i>Italy <i>NLM ID: </i>100959175 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1590-3478 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215901874%22">15901874 </searchLink><i>NLM ISO Abbreviation: </i>Neurol Sci <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35318561
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10072-022-05961-9
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 4095
    Titles:
      – TitleFull: Anti-SARS-Cov2 vaccination at the time of the COVID-19 pandemic: suspected adverse events reporting is the milestone of post-marketing surveillance.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mariottini A
      – PersonEntity:
          Name:
            NameFull: Repice AM
      – PersonEntity:
          Name:
            NameFull: Barilaro A
      – PersonEntity:
          Name:
            NameFull: Massacesi L
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2022 Jul
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1590-3478
          Numbering:
            – Type: volume
              Value: 43
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
              Type: main
ResultId 1